Guest Author
Oliver Libby of H/L Ventures outlines the key steps the venture industry needs to take "to ensure that we are behaving responsibly enough to avoid heavy-handed governance and regulation."
Attorney Carl Hessler of Lowenstein Sandler offers a refresher on deal structuring and fiduciary duties for down rounds.
Mike Collins, founder and CEO of Alumni Ventures, shares his vision for AV to ‘become the most AI-powered VC in the industry’ and the progress the firm has made so far.
The SEC brought what appears to be a record number of enforcement actions against exempt reporting advisers in 2022, write attorneys for Goodwin Procter.
The number of corporate venture capital firms has grown by more than six times since 2020. Bill Taranto of Merck Global Health Innovation Fund explains why CVCs are thriving.
Despite the general fear of a recession looming, the optimism around the emerging manager landscape was pronounced at the inaugural Emerging Manager Circle Summit.
Venture debt is coming to the forefront as start-ups confront a tightening VC market, inflation and rising interest rates., writes Nelson Chu of Percent.
Killu Sanborn of Oxford Finance and Louis Lehot of Foley & Lardner LLP explain the ins and outs of venture debt for life sciences companies.
Recruiting expert Emily Wallach shares five to-dos for early-stage investors that want to add company operators to their investment teams.
A number of seismic shifts are underway that are transforming the global economy and presenting vast opportunity for both entrepreneurs and investors, writes Ed Knight, president of Antler.